Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

27,899 signal articles · 196 in last 24h · 135,438 total before filter · latest 28m ago
196last 24h
1102last 7d
177● bullish (7d)
145● bearish (7d)
209publishers
AllMacro306Earnings354M&A79Regulatory24Product11Analyst16
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Quantinuum, Fresh Off a Federal Quantum Funding Boost, Gets IPO Pricing
Barrons.com101d agoneutral
Quantinuum, Fresh Off a Federal Quantum Funding Boost, Gets IPO Pricing

The initial public offering for Quantinuum, the quantum computing company backed by Honeywell, was priced in an encouraging sign that investors may soon have a new way to buy into the emergent technology. Quantinuum said Tuesday that it plans to sell nearly 21.1 million shares in its IPO, at an expected price range of $45 to $50 a share. A source with direct knowledge of the matter told Barron’s last year that Honeywell was looking to take the company public as soon as late 2026, market conditions permitting.

Investing.com101d agoneutral
Quantinuum targets $12.7 billion valuation in U.S. IPO

Investing.com -- Honeywell's spinoff Quantinuum plans to raise up to $1.05 billion through a U.S. initial public offering that would value the quantum computing company at up to $12.7 billion, the firm announced on Tuesday.

Bond Markets Are Reluctant Participants as Peace Hopes Fuel Stocks and Oil Prices
Barrons.com101d agoneutral
Bond Markets Are Reluctant Participants as Peace Hopes Fuel Stocks and Oil Prices

U.S. stocks looked set to test all-time highs again Tuesday, with the tech-led leading early gainers, as investors bet the war in Iran was nearing an interim peace agreement that could reopen the Strait of Hormuz and unleash energy markets ahead of the summer driving demand expected in domestic markets. Bond markets, however, remained reluctant to fully commit to the new peace talks, and yields were holding north of key levels ahead of a key set of growth and inflation figures later in the week. Talks between Washington and Tehran, however, have been punctuated by a fresh round of attacks by U.S. troops on targets in southern Iran as well as claims from Iran’s Islamic Revolutionary Guard Corps on Tuesday that it fired on a U.S. fighter jet that entered the country’s airspace.

The Question About Elon Musk That SpaceX Refuses to Answer Before Its IPO
24/7 Wall St.101d agoneutral
The Question About Elon Musk That SpaceX Refuses to Answer Before Its IPO

There’s a question floating around the biggest IPO in history, and SpaceX has chosen its words very carefully to avoid answering it. I’ve been reading pre-IPO paperwork for nearly two decades, and what’s missing from this one tells you more than what’s in it. The company is reportedly heading to NASDAQ in June 2026 at ... The Question About Elon Musk That SpaceX Refuses to Answer Before Its IPO

JPMorgan’s Matejka Sees Stocks Overpricing Risk of Rate Hikes
Bloomberg101d agoneutral
JPMorgan’s Matejka Sees Stocks Overpricing Risk of Rate Hikes

(Bloomberg) -- Markets are overpricing potential central bank interest-rate increases, creating conditions for a rally in stocks with the lowest volatility like staples and utilities, according to strategists at JPMorgan Chase & Co. Most Read from BloombergNvidia CEO Urges Super Micro to Tighten Up on ComplianceTrump Doctor Visit Renews Health Scrutiny as 80th Birthday NearsTrump Says He’ll Announce Negotiated Deal With Iran ShortlyRubio Sees Good News Coming on Hormuz as Iran Talks ContinueUS,

Investing.com101d agobullish
Micron stock surges as UBS sees more than 100% upside from here

Investing.com -- Micron Technology shares have jumped 6.3% in premarket trading to $798.37 after UBS more than tripled its price target on the memory chip giant to $1,625 from $535, citing the emergence of long-term supply agreements that the firm said will structurally transform the company’s earnings profile.

Bloomberg101d agoneutral
Honeywell-Backed Quantinuum Seeks to Raise $1.05 Billion in IPO

(Bloomberg) -- Quantinuum Inc., a quantum computing company backed by Honeywell International Inc., is seeking to raise $1.05 billion in its US initial public offering, capitalizing on investor enthusiasm for the technology. Most Read from BloombergNvidia CEO Urges Super Micro to Tighten Up on ComplianceTrump Doctor Visit Renews Health Scrutiny as 80th Birthday NearsTrump Says He’ll Announce Negotiated Deal With Iran ShortlyRubio Sees Good News Coming on Hormuz as Iran Talks ContinueUS, Iran Inc

Honeywell's Quantinuum targets $12.7 billion valuation in US IPO
Reuters101d agoneutral
Honeywell's Quantinuum targets $12.7 billion valuation in US IPO

Honeywell's Quantinuum is targeting a valuation of up ‌to $12.7 billion in its U.S. initial ‌public offering, it said on Tuesday, as ​it looks to capitalize on heightened investor attention around quantum computing. It had raised ⁠funds at a valuation of $10 billion in its latest funding round. Quantinuum, formed in 2021 after a separation from Honeywell and merger ‌with Cambridge Quantum, is ​chaired by the industrial ​giant's CEO, ​Vimal Kapur, and led ‌by Intel veteran Rajeeb Hazra.

Nokia’s 140% Rally Turns AI Comeback Into Valuation Puzzle
Bloomberg101d agobullish
Nokia’s 140% Rally Turns AI Comeback Into Valuation Puzzle

(Bloomberg) -- A rally in Nokia Oyj is forcing investors to reconsider the company not as an old telecom-equipment stock, but as part of the infrastructure underpinning the artificial intelligence boom.Most Read from BloombergNvidia CEO Urges Super Micro to Tighten Up on ComplianceTrump Doctor Visit Renews Health Scrutiny as 80th Birthday NearsTrump Says He’ll Announce Negotiated Deal With Iran ShortlyRubio Sees Good News Coming on Hormuz as Iran Talks ContinueUS, Iran Inch Toward Deal as Gaps R

Lilly Agrees to Buy Trio of Vaccine Developers
The Wall Street Journal101d agobullish
Lilly Agrees to Buy Trio of Vaccine Developers

Eli Lilly agreed to acquire three vaccine developers in deals worth up to nearly $4 billion combined, the company told The Wall Street Journal. Indianapolis-based Lilly has agreed to acquire Curevo, LimmaTech Biologics and Vaccine Co. Curevo is developing a shingles vaccine that Lilly believes could be as effective as the current standard but with reduced side effects, said Daniel Skovronsky, Lilly’s chief scientific and product officer.

PDBC Promises Diversified Commodities Without K-1 Tax Forms, But the Workaround Hides a Long Term Roll Cost
24/7 Wall St.101d agoneutral
PDBC Promises Diversified Commodities Without K-1 Tax Forms, But the Workaround Hides a Long Term Roll Cost

The Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF (NASDAQ:PDBC) exists to solve one specific tax-season headache. Investors who want broad commodity exposure as an inflation hedge typically face the choice between owning a partnership-structured fund that ships a K-1 every spring or skipping the asset class entirely. PDBC threads that needle with a ... PDBC Promises Diversified Commodities Without K-1 Tax Forms, But the Workaround Hides a Long Term Roll Cost